Media
News
Are you a media representative looking for content on Bayer? This section provides access to media releases as well as feeds from our social media channels.
25 - 32of about 37 News
25 - 32of about 37 News
Bayer Fund shares over $100,000 in funding with students through its Opportunity Scholarship Program
European Society of Cardiology recommends (rivaroxaban) XARELTO® 2.5 mg plus acetylsalicylic acid for patients at high risk of heart attacks, strokes and death due to chronic coronary syndromes
Health Canada approves VITRAKVI® (larotrectinib), the first tumour agnostic cancer treatment for advanced solid tumours harbouring an NTRK gene fusion
Bayer Fund to provide nearly $100,000 in scholarships to eligible Canadian high school students in 2019